PLATELET-RICH PLASMA (PRP) AND ITS PLATELET CONCENTRATION HELP ALLEVIATE OSTEOARTHRITIS SYMPTOMS: OUR HOSPITAL EXPERIENCE

Main Article Content

Sundas Asad
Eslam Mohammed Shalaby
Niaz Hussain Keerio
Zulfiqar Haider Kerawala
Mohammed Asif Peracha
Azizullah Bhayo

Keywords

Platelet-Rich Plasma (PRP), knee arthritis, osteoarthritis, effectiveness

Abstract

Background: Osteoarthritis is a disorder that mainly affects the cartilage in synovial joints, resulting in localized damage and sclerosis of the subchondral bone. It is the most prevalent type of joint disease worldwide and is closely linked to aging. The World Health Organization (WHO) states that osteoarthritis is the primary cause of severe, persistent pain and physical disability, affecting a large number of people worldwide. Platelet-Rich Plasma, (PRP), is a concentrated form of human platelets that is higher than the body's typical platelet count. PRP has been used in surgical procedures since 1987 to promote cell regeneration, and a significant amount of evidence supports its efficaciousness as a treatment for tendinosis.


Objective: To ascertain the effectiveness of platelet-rich plasma (PRP) in the early stages of knee articular arthritis.


Study design: A cross-sectional study


Place and Duration: This study was conducted in Peoples Medical College & Hospital Nawabshah from July 2022 to July 2023


Methodology: There were a total of 150 people involved in this study, and this sample was calculated using a non-probability convenient sampling technique. The participants of this study were those who were diagnosed with early knee osteoarthritis. A 30–40 cc venous blood sample was taken from the ante-cubital vein and put in a sterile tube containing anticoagulant dextrose solution A (ACDA) in order to create 4-5 cc of Platelet-Rich Plasma (PRP) with a platelet concentration 4-6 times greater than the normal values. WOMAC and VAS scores were used to evaluate the outcomes. SPSS version 20 was used to analyze the data. A p-value of less than 0.05 was considered significant.


Results: There are a total of 150 participants in this research. Out of these 150 people, there were 108 (72%) females, and the rest 42 were males. The mean age of the participants was 56.14 years. The average weight of the participants was 84.24 kg. Overall, 132 people had difficulty sitting on the floor. A total of 78 people had the right joint involvement. The mean VAS score before PRP was 7.21, and at 6 months, it was 5.12. A total of 74 patients had a satisfactory outcome, 46 participants had a fair outcome, and 30 people had a poor outcome.


Conclusion: One economical and minimally intrusive way to treat early-stage degenerative knee joint cartilage lesions is to use Platelet-Rich Plasma (PRP).

Abstract 54 | PDF Downloads 17

References

1. Ghori FS, Farooq MA, Khan KM. Effect of Plasma Enriched with Platelets in Mild to Moderate Osteoarthritis of Knee Joint. Journal of Pakistan Orthopaedic Association. 2023 Jun 14;35(2):23-8.
2. Saqlain HAU, Hussaine SS, Keerio NH, Qureshi MA, Valecha NK, Noor SS. Effect of platelet rich plasma injection effect of knee osteoarthritis in elderly: single dose versus double dose randomised clinical trial. J. Pharm. Res. Int. 2021; 33: 84–9
3. Wu YT, Hsu KC, Li TY, Chang CK, Chen LC. Effects of platelet-rich plasma on pain and muscle strength in patients with knee osteoarthritis. American journal of physical medicine & rehabilitation. 2018 Apr 1;97(4):248-54.
4. Adatia A, Rainsford KD, Kean WF (2012) Osteoarthritis of the knee and hip. Part I: aetiology and pathogenesis as a basis for pharmacotherapy. J Pharm Pharmacol 64:617–625 2
5. Heidari B (2011) Knee osteoarthritis prevalence, risk factors, pathogenesis and features: part I. Casp J Intern Med 2:205– 212
6. Blagojevic M, Jinks C, Jeffery A, Jordan KP (2010) Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthr Cartil 18:24–33
7. Murphy L, Helmick CG (2012) The impact of osteoarthritis in the United States. Orthop Nurs 31:85–91
8. Engebretsen L, Steffen K, Alsousou J, Anitua E, Bachl N, Devilee R, Everts P, Hamilton B, Huard J, Jenoure P and Kelberine F, (2010) IOC consensus paper on the use of platelet-rich plasma in sports medicine. British Journal of Sports Medicine 44(15):1072–1081
9. Ficek K, Kamiński T, Wach E, Cholewiński J, Cięszczyk P (2011) Application of platelet rich plasma in sports medicine. J Hum Kinet 30:85–97
10. Fernandes G, Yang S (2016) Application of platelet-rich plasma with stem cells in bone and periodontal tissue engineering. Bone Res 4:16036
11. Michael JW-P, Schlüter-Brust KU, Eysel P (2010) The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee. Dtsch Aerzteblatt Online 107:152– 162
12. Cerza F, Carnì S, Carcangiu A et al (2012) Comparison between hyaluronic acid and platelet-rich plasma, intraarticular infiltration in the treatment of gonarthrosis. Am J Sports Med 40:2822–2827
13. Cole BJ, Karas V, Hussey K et al (2017) Hyaluronic acid versus platelet-rich plasma: a prospective, double-blind randomized controlled trial comparing clinical outcomes and effects on intra-articular biology for the treatment of knee osteoarthritis. Am J Sports Med 45:339–346
14. Filardo G, Kon E, Di Martino A, Di Matteo B, Merli ML, Cenacchi A, Fornasari PM, Marcacci M (2012a) Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC Musculoskelet Disord 13:229
15. Michael JW-P, Schluter-Brust KU, Eysel P(2010) The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee. Dtsch Aerztblatt Online 107:152- 162
16. Keerio NH, Aamir N, Kumar N, Qureshi MA, us Saqlain HA, Noor SS. Incidence of writing double NSAIDs in a single prescription for osteoarthritis. The Professional Medical Journal. 2021 May 10;28(05):702-6.
17. Dhillon MS, Patel S, John R (2017) PRP in OA knee – update, current confusions and future options. Sicot-J 3:27
18. KonE1, Mandelbaum B, Buda R, Filardo G, Decolgiano M, Temoncini A et al: Platelet rich plasma intra articular injection versus hyaluronic and viscosupplementation as treatments for cartilage pathology from early degeneration to osteoarthritis Clin J Sport Med 2013;23(3):238-239
19. Halpern B, Chaudhury S, Rodeo SA, Hayter C, Bogner E, Potter HG, Nguyen J. Clinical and MRI outcomes after platelet-rich plasma treatment for knee osteoarthritis. Clin J Sport Med. 2013 May;23(3):238-9. doi: 10.1097/JSM.0b013e31827c3846. PubMed PMID: 23238250.
20. Gobbi A, Karnatzikos G, Mahajan V, Malchira S. Platelet-rich plasma treatment in symptomatic patients with knee osteoarthritis: preliminary results in a group of active patients. Sports Health. 2012;4(2):162-72.

Most read articles by the same author(s)